New York State Common Retirement Fund’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-49,739
| Closed | -$1M | – | 3375 |
|
|
2021
Q3 | $1M | Sell |
49,739
-10,285
| -17% | -$284K | ﹤0.01% | 2110 |
|
|
2021
Q2 | $2.24M | Buy |
60,024
+524
| +0.9% | +$16.1K | ﹤0.01% | 1806 |
|
|
2021
Q1 | $1.52M | Hold |
59,500
| – | – | ﹤0.01% | 1935 |
|
|
2020
Q4 | $1.31M | Hold |
59,500
| – | – | ﹤0.01% | 1908 |
|
|
2020
Q3 | $1.07M | Hold |
59,500
| – | – | ﹤0.01% | 1876 |
|
|
2020
Q2 | $1.51M | Buy |
59,500
+13,000
| +28% | +$280K | ﹤0.01% | 1665 |
|
|
2020
Q1 | $854K | Hold |
46,500
| – | – | ﹤0.01% | 1798 |
|
|
2019
Q4 | $1.02M | Sell |
46,500
-7,400
| -14% | -$149K | ﹤0.01% | 1943 |
|
|
2019
Q3 | $774K | Hold |
53,900
| – | – | ﹤0.01% | 2111 |
|
|
2019
Q2 | $849K | Hold |
53,900
| – | – | ﹤0.01% | 2098 |
|
|
2019
Q1 | $790K | Buy |
53,900
+11,500
| +27% | +$132K | ﹤0.01% | 2089 |
|
|
2018
Q4 | $453K | Sell |
42,400
-7,000
| -14% | -$92.1K | ﹤0.01% | 2333 |
|
|
2018
Q3 | $754K | Hold |
49,400
| – | – | ﹤0.01% | 2228 |
|
|
2018
Q2 | $605K | Buy |
+49,400
| New | +$621K | ﹤0.01% | 2371 |
|
|
2016
Q2 | – | Sell |
-13,800
| Closed | -$74K | – | 3220 |
|
|
2016
Q1 | $74K | Hold |
13,800
| – | – | ﹤0.01% | 2995 |
|
|
2015
Q4 | $164K | Hold |
13,800
| – | – | ﹤0.01% | 2862 |
|
|
2015
Q3 | $113K | Buy |
13,800
+2,704
| +24% | +$31.2K | ﹤0.01% | 3000 |
|
|
2015
Q2 | $155K | Buy |
+11,096
| New | +$204K | ﹤0.01% | 3002 |
|
Other funds holding DRNA
New York State Common Retirement Fund's DRNA Position: Q4 2021 in Review
New York State Common Retirement Fund sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 49,739 shares — an estimated $1M sold.
New York State Common Retirement Fund first reported a position in DRNA in Q2 2015 and held it in 18 quarters. The position peaked at $2.24M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- New York State Common Retirement Fund reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- New York State Common Retirement Fund sold 49,739 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $1M.
- New York State Common Retirement Fund first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2015 and held it in 18 quarters.
- New York State Common Retirement Fund's Dicerna Pharmaceuticals, Inc. position peaked at $2.24M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on New York State Common Retirement Fund's 13F filing for Q4 2021, filed 2 Feb 2022.